Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Autoimmune cytopenias in chronic lymphocytic leukemia, facts and myths.

Tandra P, Krishnamurthy J, Bhatt VR, Newman K, Armitage JO, Akhtari M.

Mediterr J Hematol Infect Dis. 2013 Nov 4;5(1):e2013068. doi: 10.4084/MJHID.2013.068. Review.

3.

Autoimmune cytopenias in chronic lymphocytic leukemia.

D'Arena G, Guariglia R, La Rocca F, Trino S, Condelli V, De Martino L, De Feo V, Musto P.

Clin Dev Immunol. 2013;2013:730131. doi: 10.1155/2013/730131. Epub 2013 Apr 16. Review.

4.

A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.

Tsang M, Parikh SA.

Curr Hematol Malig Rep. 2017 Feb;12(1):29-38. doi: 10.1007/s11899-017-0366-1. Review.

PMID:
28197963
5.
6.

Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.

D'Arena G, Laurenti L, Capalbo S, D'Arco AM, De Filippi R, Marcacci G, Di Renzo N, Storti S, Califano C, Vigliotti ML, Tarnani M, Ferrara F, Pinto A.

Am J Hematol. 2006 Aug;81(8):598-602.

7.

Autoimmune complications of chronic lymphocytic leukemia.

Hamblin TJ.

Semin Oncol. 2006 Apr;33(2):230-9. Review.

PMID:
16616070
8.

Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.

Rossignol J, Michallet AS, Oberic L, Picard M, Garon A, Willekens C, Dulery R, Leleu X, Cazin B, Ysebaert L.

Leukemia. 2011 Mar;25(3):473-8. doi: 10.1038/leu.2010.278. Epub 2010 Dec 3.

PMID:
21127498
9.

Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.

Gentile M, Lucia E, Iorio C, Vigna E, Mazzone C, Morelli R, Bisconte MG, Gentile C, Morabito F.

Cancer Chemother Pharmacol. 2008 Sep;62(4):741-3. Epub 2007 Dec 7.

PMID:
18064461
10.

Mechanism of autoimmune hemolytic anemia in chronic lymphocytic leukemia.

Sthoeger ZM, Sthoeger D, Shtalrid M, Sigler E, Geltner D, Berrebi A.

Am J Hematol. 1993 Aug;43(4):259-64.

PMID:
7690517
11.

Autoimmune cytopenias in chronic lymphocytic leukemia.

Visco C, Barcellini W, Maura F, Neri A, Cortelezzi A, Rodeghiero F.

Am J Hematol. 2014 Nov;89(11):1055-62. doi: 10.1002/ajh.23785. Epub 2014 Jul 7. Review.

12.

Disease-specific complications of chronic lymphocytic leukemia.

Dearden C.

Hematology Am Soc Hematol Educ Program. 2008:450-6. doi: 10.1182/asheducation-2008.1.450.

PMID:
19074125
13.

Chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.

D'Arena G, Cascavilla N.

Leuk Lymphoma. 2007 Jun;48(6):1072-80. Review.

PMID:
17577769
14.
15.

Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia.

Gupta N, Kavuru S, Patel D, Janson D, Driscoll N, Ahmed S, Rai KR.

Leukemia. 2002 Oct;16(10):2092-5.

16.

Restricted immunoglobulin VH region repertoire in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia.

Efremov DG, Ivanovski M, Siljanovski N, Pozzato G, Cevreska L, Fais F, Chiorazzi N, Batista FD, Burrone OR.

Blood. 1996 May 1;87(9):3869-76.

17.

Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lymphomas.

Hauswirth AW, Skrabs C, Schützinger C, Gaiger A, Lechner K, Jäger U.

Leuk Lymphoma. 2007 Jun;48(6):1139-49. Review.

PMID:
17577777
18.

Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1,518 cases.

Shvidel L, Tadmor T, Braester A, Bairey O, Rahimi-Levene N, Herishanu Y, Klepfish A, Shtalrid M, Berrebi A, Polliack A; Israeli CLL Study Group (ICLLSG).

Ann Hematol. 2013 May;92(5):661-7. doi: 10.1007/s00277-012-1663-3. Epub 2012 Dec 29.

PMID:
23274356
19.

Basic biology of autoimmune phenomena in chronic lymphocytic leukemia.

Pritsch O, Maloum K, Dighiero G.

Semin Oncol. 1998 Feb;25(1):34-41. Review.

PMID:
9482525
20.

Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors.

Borthakur G, O'Brien S, Wierda WG, Thomas DA, Cortes JE, Giles FJ, Kantarjian HM, Lerner S, Keating MJ.

Br J Haematol. 2007 Mar;136(6):800-5.

PMID:
17341265

Supplemental Content

Support Center